We previously found that pigeon IgG possesses unique N-glycan structures that contain the Gal␣1-4Gal1-4Gal1-4GlcNAc sequence at their nonreducing termini. This sequence is most likely produced by putative ␣1,4-and 1,4-galactosyltransferases (GalTs), which are responsible for the biosynthesis of the Gal␣1-4Gal and Gal1-4Gal sequences on the N-glycans, respectively. Because no such glycan structures have been found in mammalian glycoproteins, the biosynthetic enzymes that produce these glycans are likely to have distinct substrate specificities from the known mammalian GalTs. To study these enzymes, we cloned the pigeon liver cDNAs encoding ␣4GalT and 4GalT by expression cloning and characterized these enzymes using the recombinant proteins. The deduced amino acid sequence of pigeon ␣4GalT has 58.2% identity to human ␣4GalT and 68.0 and 66.6% identity to putative ␣4GalTs from chicken and zebra finch, respectively. Unlike human and putative chicken ␣4GalTs, which possess globotriosylceramide synthase activity, pigeon ␣4GalT preferred to catalyze formation of the Gal␣1-4Gal sequence on glycoproteins. In contrast, the sequence of pigeon 4GalT revealed a type II transmembrane protein consisting of 438 amino acid residues, with no significant homology to the glycosyltransferases so far identified from mammals and chicken. However, hypothetical proteins from zebra finch (78.8% identity), frogs (58.9 -60.4%), zebrafish (37.1-43.0%), and spotted green pufferfish (43.3%) were similar to pigeon 4GalT, suggesting that the pigeon 4GalT gene was inherited from the common ancestors of these vertebrates. The sequence analysis revealed that pigeon 4GalT and its homologs form a new family of glycosyltransferases.